The company's purpose is the invention and development of organic compounds as synergistic adjuvants to enhance the action of tyrosine-kinase inhibitors (TKIs), which are the enzymes responsible for the proliferation of malignant tumors; obtaining patents to protect the inventions; any collaboration with pharmaceutical and biotechnology companies to valorize its patents through licenses (for full purpose see articles of association).
Commercial register, canton of VD·As of August 9, 2016View on Zefix
Comparisons
PharmOxaco Sàrl in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank PharmOxaco Sàrl by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.